Investigating heart failure? Recognise typical symptoms and learn about classification criteria, the importance of heart rate in the development of heart failure and the role of beta blockers and other therapies in treatment
ATTENTION! Kindly note that if you were in attendance of the live webinar you have already received 1 CPD point and will not be permitted to receive additional points for the report. Should this occur, the HPCSA will only record the 1 CPD point from the live webinar, invalidating any additional CPD points from the report.
Quiz-summary
0 of 15 questions completed
Questions:
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
Information
You have already completed the module before. Hence you can not start it again.
Module is loading…
You have to finish following quiz, to start this quiz:
Results
Results
Time has elapsed
Categories
- Not categorized 0%
-
Thank you, we will review your submission and notify you of your results via email.If not received within 5 hours due to spam, don’t worry, it will show in your profile.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- Answered
- Review
- Question 1 of 15
1. Question
1. Heart failure mortality rates are higher than cancer mortality rates.
- Question 2 of 15
2. Question
2. The lifetime risk of heart failure at age 55 years is ___ for men.
- Question 3 of 15
3. Question
3. Which statement is incorrect? With respect to heart failure:
- Question 4 of 15
4. Question
4. The most common heart failure presentation is:
- Question 5 of 15
5. Question
5. Which statement is correct? With respect to heart failure:
- Question 6 of 15
6. Question
6. Targets for heart failure drug intervention include:
- Question 7 of 15
7. Question
7. Beta blockers are contraindicated in the patient with heart failure.
- Question 8 of 15
8. Question
8. Activation of the sympathetic nervous system by ACE-inhibitors leads to:
- Question 9 of 15
9. Question
9. Which statement is incorrect? With respect to heart rate:
- Question 10 of 15
10. Question
10. The CIBIS II study of beta blocker therapy demonstrated that, as compared to placebo, bisoprolol reduced mortality by ___.
- Question 11 of 15
11. Question
11. The CIBIS II study demonstrated that, as compared to placebo, bisoprolol reduced:
- Question 12 of 15
12. Question
12. The range of effects of beta blockers in heart failure include:
- Question 13 of 15
13. Question
13. There is an evidence base that spironolactone increases heart failure survival in patients with HFrEF.
- Question 14 of 15
14. Question
14. Which statement is correct?
- Question 15 of 15
15. Question
15. Which statement is incorrect? With respect to SGLT-2 inhibitors, benefit for heart failure patients has been demonstrated in those:
Do you like this? Share with a colleague
[DISPLAY_ULTIMATE_SOCIAL_ICONS]